(Q41739721)

8 October 2017

Immunoscintigraphy of Hodgkin's disease: In vivo use of radiolabelled monoclonal antibodies derived from Hodgkin cell lines (English)

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90019-P

31 October 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694088

31 October 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90019-P

31 October 2022

author name string

P. Carde

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694088

31 October 2022

L. Da Costa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694088

31 October 2022

L. Manil

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694088

31 October 2022

M. Pfreundschuh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694088

31 October 2022

J. D. Lumbroso

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694088

31 October 2022

J. C. Saccavini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694088

31 October 2022

B. Caillou

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694088

31 October 2022

M. Ricard

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694088

31 October 2022

F. Boudet

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694088

31 October 2022

M. Hayat

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694088

31 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1694088

31 October 2022

publication date

1 April 1990

1 reference

full work available at URL

8 October 2017

https://api.elsevier.com/content/article/PII:027753799090019P?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90019-P

https://api.elsevier.com/content/article/PII:027753799090019P?httpAccept=text/plain

31 October 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90019-P

European Journal of Cancer

31 October 2022

published in

1 reference

8 October 2017

26

1 reference

8 October 2017

474-479

1 reference

8 October 2017

4

1 reference

Hodgkin's disease: establishment and characterization of four in vitro cell lies

8 October 2017

2

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90019-P

Phenotypic and genotypic analysis of Hodgkin's disease derived cell lines: histopathological and clinical implications

31 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90019-P

Hodgkin and Reed-Sternberg cell associated monoclonal antibodies HRS-1 and HRS-2 react with activated cells of lymphoid and monocytoid origin

31 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90019-P

Evaluation of protocols for purification of mouse monoclonal antibodies. Yield and purity in two-dimensional gel electrophoresis

31 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90019-P

Immunolymphoscintigraphy in patients with lymphoma after subcutaneous injection of indium-111-labeled T101 monoclonal antibody

31 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90019-P

Computed tomography, lymphography, and staging laparotomy: correlations in initial staging of Hodgkin disease

31 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90019-P

A multivariate analysis of prognostic factors in early stage Hodgkin's disease

31 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90019-P

The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984.

31 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90019-P

Clinical stages I and II Hodgkin's disease: a specifically tailored therapy according to prognostic factors.

31 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90019-P

Clinicopathologic studies of 117 untreated patients subjected to laparotomy for the staging of Hodgkin's disease

31 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90019-P

Results of treating Hodgkin's disease without a policy of laparotomy staging

31 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90019-P

The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease

31 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90019-P

Isotopic immunoglobulin: a new systemic therapy for advanced Hodgkin's disease

31 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90019-P

Detection of specific anti-antibodies in patients treated with radiolabeled antibody

31 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90019-P

Monoclonal antibodies for use in radiotherapy and diagnosis

31 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0277-5379(90)90019-P

31 October 2022

Identifiers

1 reference

8 October 2017

1 reference